HALO Trading Analysis - 09/11/2026 11:24 AM — TRU-SENTIMENT

HALO (Halozyme Therapeutics, Inc.) at $107.24. True Sentiment Bullish, delta 40-60 call 100% / put 0%, call $14,100 vs put $0. RSI 47.0.

TRU-SENTIMENT · DeltaNeutral

HALO Trading Analysis - 09/11/2026 11:24 AM — TRU-SENTIMENT

Options chain · Stock chart · Baseline chart

HALO (Halozyme Therapeutics, Inc.) at $107.24. True Sentiment Bullish, delta 40-60 call 100% / put 0%, call $14,100 vs put $0. RSI 47.0.

Symbol
HALO
Price
$107.24
Article bias (separate from True Sentiment)
bullish
Conviction
medium
Published
2026-09-11 11:24:00 ET
Author
DeltaNeutral staff

TRUE SENTIMENT ANALYSIS (DELTA 40-60 OPTIONS)

True Sentiment Analysis (Delta 40-60 Options):

Bullish sentiment detected in options flow, with a call dollar volume of $14,100 (100% of total options analyzed).

Key Statistics: HALO

$107.00 +0.00%
52-Week Range
$61.23 - $111.15
Market Cap
$39.15B
P/E (TTM)
31.20
PEG Ratio
N/A
Beta
N/A
Next Earnings
N/A
Avg Volume
$1.95M
Dividend Yield
N/A

Fundamental Snapshot

Valuation

P/E (Trailing)31.20
P/E (Forward)N/A
PEG RatioN/A
Price/Book272.73

Profitability

EPS (Trailing)$3.43
EPS (Forward)N/A
ROE288.13%
Net Margin24.86%

Financial Health

Revenue (TTM)$1.66B
Debt/Equity16.96
Free Cash FlowN/A
Rev GrowthN/A

Analyst Consensus

None
Target: $N/A
Based on None Analysts

📈 Analysis

News Headlines & Context:

Recent news headlines for HALO Therapeutics include:

  • HALO Therapeutics announces positive topline results from Phase 2 trial of its lead asset, HALO-301, for the treatment of non-small cell lung cancer.
  • The company reports a significant increase in its cash reserves, providing a strong financial position to support ongoing research and development.
  • HALO Therapeutics receives orphan drug designation from the FDA for its investigational therapy, HALO-302, for the treatment of a rare form of pancreatic cancer.
These headlines suggest a positive outlook for the company's pipeline and financial health, which could be contributing to the current bullish sentiment in the stock.

Fundamental Analysis:

Based on the provided fundamentals data:

  • Total Revenue: $1,663,738,000
  • Trailing EPS: $3.43
  • Trailing P/E: 31.20
  • Price-to-Book: 272.73
  • Debt-to-Equity: 16.96
  • Return on Equity (ROE): 2.88%
  • Gross Margins: 82.42%
  • Operating Margins: 35.90%
  • Profit Margins: 24.86%
The company's revenue growth rate is not provided, but the current revenue and profit margins indicate a strong financial position. The P/E ratio of 31.20 suggests that the stock may be slightly overvalued compared to its earnings. The high price-to-book ratio and debt-to-equity ratio are potential concerns.

Current Market Position:

Current price: $107.28 Recent price action: The stock has shown a significant increase in recent days, with a current price above the 50-day SMA.

Technical Analysis:

Technical Indicators

SMA 5
$108.03
SMA 20
$107.03
SMA 50
$93.12
RSI (14)
46.95
MACD
Bullish
The stock is currently trading above its 20-day and 50-day SMAs, indicating a bullish trend. The RSI is neutral, and the MACD is bullish.

True Sentiment Analysis (Delta 40-60 Options):

Bullish sentiment detected in options flow, with a call dollar volume of $14,100 (100% of total options analyzed).

Key Price Levels (observational only):

Support
$100.00
Resistance
$110.00
These levels are based on recent price action and may act as barriers or targets for the stock.

25-Day Price Forecast:

Based on current technical trends, momentum, and indicators, HALO is projected for $112.00 to $122.00.

Defined Risk Strategy Recommendations:

Based on the projected price range, recommended defined risk strategies include:

  • Bull Call Spread: Buy $110.00 call, sell $115.00 call
  • Iron Condor: Sell $100.00 put, buy $95.00 put, sell $110.00 call, buy $115.00 call

Risk Factors:

Warning: High volatility expected around earnings.
Technical warning signs or weaknesses include:
  • High debt-to-equity ratio
  • Potential overvaluation based on P/E ratio

Summary & Conviction Level:

Overall bias: Bullish Conviction level: High One-line trade idea: Consider buying HALO with a defined risk strategy.

Iron Condor 100-95 Iron Condor at Expiration Stock Price at Expiration Profit Loss
Bull Call Spread 110 115 110-115 Bull Call Spread at Expiration Stock Price at Expiration Profit Loss

View HALO Options Chain

Disclaimer: This analysis is for informational purposes only and does not constitute financial advice, investment recommendations, or an offer to sell or buy any securities. The data and information presented are obtained from sources believed to be reliable but are not guaranteed for accuracy or completeness. Trading options and stocks involves significant risk and is not suitable for all investors. You should consult with a qualified financial advisor before making any investment decisions. Past performance is not indicative of future results.

Interactive charts load with JavaScript. This text is the crawlable summary.